MedTrace Logo

Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy

NCT01239680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2014-06-17

Study results available
· View outcomes & findings →

Summary

Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.

Conditions

  • Hemorrhagic Shock

Interventions

DRUG

Glutamine

Intravenous 25 grams once over 6 hours

DRUG

Ringer's Lactate

Intravenous 1 liter once over 6 hours

DRUG

Placebo (for Glutamine)

Given Intravenously in 1 liter Lactated Ringer's

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Missouri, Kansas City

    lead OTHER

Principal Investigators

  • Charles Van Way, III, M.D. · University of Missouri, Kansas City

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01239680 on ClinicalTrials.gov